NEWS & EVENTS

 
 

Conferences with our Presentations and Abstracts

Jan 10- 12, 2019 

American Society of Transplant Surgeons 

ASTS Winter Symposium, Miami, FL 

 

Fillman N. Does CXCL8 inhibitor (Reparixin) improve islet engraftment and clinical outcomes after islet allotransplantation? University of Chicago preliminary results from a phase 3 multicenter randomized, double-blinded, prospective study.

selected for oral presentation

Jan 27-30, 2019 

8th EPITA Symposium

Innsbruck, Austria

 

Golebiewska J. Does CXCL8 inhibitor (Reparixin) improve islet engraftment and clinical outcomes after islet allotransplantation? University of Chicago preliminary results from a phase 3 multicenter randomized, double-blinded, prospective study.

selected for oral presentation

Feb 19, 2019

26th Annual Charles B. Huggins Symposium, Chicago, IL

1. Para M/ Damian Grybkowski. Pain resolution and glycemic control in pediatric patients after total pancreatectomy with islet cell autotransplantation for chronic pancreatitis.- selected for oral presentation.

 

2. Antic F. Is there any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?

3. Bachul P. Does a new CXCR8 inhibitor (Reparixin) improve islet cell engraftment and clinical outcomes after pancreatic islet allotransplantation in patients with type 1 diabetes mellitus? A randomized, double blind, prospective study.

 

May 16-18, 2019

Polish Diabetes Society, Lublin, Poland 

Golebiewska J. Pancreatic Islet Transplantation in a patient with brittle T1DM after kidney and pancreas transplantation. 

May 19-22, 2019

American Pediatric Surgeon Association  Annual Meeting. Boston, MA 

Fillman N,/Slidell M. Pain resolution and glycemic control in pediatric patients after total pancreatectomy with islet cell autotransplantation for chronic pancreatitis. 

June 1-5, 2019

American Transplant Congress

Boston, MA 

Bachul P. Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study. 

Perez Gutierrez A. KDPI Significantly Correlates With Reperfusion Biopsy Findings

June 7-11, 2019

American Diabetes Association,

79th Scientific Sessions, San Francisco, CA

Oral presentations:

1. Grybowski D. BETA-2 Calculated Based on Single Fasting Blood Sample Allows to Define and Discriminate between Optimal and Suboptimal Islet Allograft Function Prior to the Clinical Need for Insulin Support.                                                        Read       Link                

2. Bachul P. Does the Reparixin (CXCR1/2 Inhibitor) Improve Islet Cell Engraftment and Clinical Outcomes after Pancreatic Islet Allotransplantation in Patients with Type 1 Diabetes Mellitus? A Randomized, Double-Blind, Prospective Study.    Read        Link 

3. Anteby R/Luncander A. Is There Any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?                                                                                 Read       Link 

 

July 2-5, 2019 

International Pancreas and Islet Transplantation Association

17th World Congress, Lyon, France 

Oral presentations:

 

1. P Bachul. Is there any Prognostic Value of Diabetes-Associated Autoantibody Levels for Predicting Islet Graft Function in Patients with Long-Standing Type 1 Diabetes Mellitus?

2. Golebiewska. BETA-2 Based On Single Fasting Blood Sample Allows To Define and Discriminate Optimal And Suboptimal Islet Allograft Function Prior to The Need For Reintroduction of Insulin Support.

3. Bachul P. Does A CXCR1/2 Inhibitor (Reparixin) Improve Islet Cell Engraftment And Clinical Outcomes After Pancreatic Islet Allotransplantation In Patients With Type 1 Diabetes Mellitus? Results of A Randomized, Double Blind, Prospective Study from the University of Chicago.

4. Golebiewska J. Utilization of an "old school" supplemental purification technique allowed safe intraportal pancreatic islet transplantation. The first case ofislet allotransplantation in Medical University of Gdańsk, Poland. 

5. Bellin M. A Randomized and Blinded Trial of Infusion of the CXCL8-inhibitor Reparixin in Autologous Islet Transplant Recipients.

Jan 15- 18, 2018 

American Society of Transplant Surgeons 

ASTS Winter Symposium, Miami, FL 

 

Bachul P. Utilization of BETA-2 score for early detection of islet allograft decline and monitoring of islet function

Jan 15- 18, 2018 

American Society of Transplant Surgeons 

ASTS Winter Symposium, Miami, FL 

 

Bachul P. Utilization of BETA-2 score for early detection of islet allograft decline and monitoring of islet function

Jan 21-24, 2018 

8th EPITA Symposium

Innsbruck, Austria

 

1. Golebiewska J. Assessment of simple indices based on a single fasting blood sample in search for an optimal tool to estimate beta cell function after total pancreatectomy with islet autotransplantation.

2. Bachul P. BETA-2 score for early detection of islet allograft decline and monitoring of islet function

Feb 28, 2018

The 25th Annual Charles Huggins Research Symposium

UCMC, Chicago, IL

1. Bachul P. Estimation of beta cell function after total pancreatectomy with islet autotransplantation using single fasting blood sample based indices and modified Igls score

2. Fillman N. External validation of the newly developed BETA-2 scoring system for pancreatic islet graft function assessment

3. Fillman N. BETA-2 score is an excellent tool for monitoring of islet allograft function and early detection of transplant dysfunction

4. Kijek M. Pain resolution with good glucose control in pediatric patients with chronic pancreatitis after total pancreatectomy with islet cell autotransplantation

5. Kijek M. Broad Non-Neuraxial Analgesia Reduces Risk of Portal Vein Thrombosis After Total Pancreatectomy and Autologous Islet Transplantation Comparing to the Neuraxial Analgesia with the adequate postoperative pain control

6. Pavelko Y. Early infectious complications post total pancreatectomy with islet autotransplantation

Jun 2-6, 2018

American Transplant Congress (ATC)

Seattle, WA

1. Golebiewska J. Early infectious complications post total pancreatectomy with islet autotransplantation. READ

2. Golebiewska J. Estimation of beta cell function after total pancreatectomy with islet autotransplantation using single fasting blood sample based indices and modified Igls score

3. Bachul P. BETA-2 score is an excellent tool for monitoring of islet allograft function and early detection of transplant dysfunction

Jun 30-

Jul 5, 2018

27th International Congress of The Transplantation Society (TTS) Madrid, Spain

1. Golebiewska J. Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after total pancreatectomy with islet autotransplantation  

2. Golebiewska J. Early infectious complications post total pancreatectomy with islet autotransplantation. READ

3. Bachul P. BETA-2 score allows for convenient and precise monitoring of islet function and early detection of islet dysfunction

CONTACT:

 

 

 

 

 

 

 

 

Transplantation Institute

Clinical  Research Center

 

Islet and Kidney Transplantation

Manager, Lindsay Basto RN MSN 

Lindsay.Basto@uchospitals.edu

tel. (773) 702-2504

fax (773) 926-0671

 

Islet and Cell Processing and Research

Manager, Karolina Golab, PhD

kgolab@surgery.bsd.uchicago.edu


Transplantation Institute

University of Chicago Medicine

5841 S. Maryland Avenue

MC 5026, J-517

Chicago IL 60637

Polish-American Transplant Center

Clinical Coordinator

Patrycja Ulijaszyk RN 

Patrycja.Ulijaszyk@uchospitals.edu

  • Facebook - Grey Circle
  • Twitter - Grey Circle

© 2018 by Kajetan Witkowski